FDA NDC Directory · JSON-LD · Markdown

POLYMYXIN B

NDC 63323-321 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namePOLYMYXIN B SULFATE
Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA065372
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAMUSCULAR INTRATHECAL INTRAVENOUS OPHTHALMIC
Active ingredientsPOLYMYXIN B SULFATE (500000 [USP'U]/1)
Marketing started20091117
Package count1

External sources

Source: openFDA. Public-domain (CC0).